End-stage renal disease causes skewing in the TCR Vβ-repertoire primarily within CD8+ T Cell subsets by Huang, L. (Ling) et al.
December 2017 | Volume 8 | Article 18261
Original research
published: 15 December 2017
doi: 10.3389/fimmu.2017.01826
Frontiers in Immunology | www.frontiersin.org
Edited by: 
Valquiria Bueno, 
Federal University of 
São Paulo, Brazil
Reviewed by: 
Stephen H. Benedict, 
University of Kansas, United States 
Jennifer Ann Juno, 
University of Melbourne, Australia
*Correspondence:
Nicolle H. R. Litjens  
n.litjens@erasmusmc.nl
Specialty section: 
This article was submitted 
to Inflammation, 
a section of the journal 
Frontiers in Immunology
Received: 02 October 2017
Accepted: 04 December 2017
Published: 15 December 2017
Citation: 
Huang L, Betjes MGH, Klepper M, 
Langerak AW, Baan CC and 
Litjens NHR (2017) End-Stage Renal 
Disease Causes Skewing in the 
TCR Vβ-Repertoire Primarily 
within CD8+ T Cell Subsets. 
Front. Immunol. 8:1826. 
doi: 10.3389/fimmu.2017.01826
end-stage renal Disease causes 
skewing in the Tcr Vβ-repertoire 
Primarily within cD8+ T cell subsets
Ling Huang1, Michiel G. H. Betjes1, Mariska Klepper1, Anton W. Langerak2, Carla C. Baan1 
and Nicolle H. R. Litjens1*
1 Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, Nephrology and Transplantation, Rotterdam, 
Netherlands, 2 Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands
A broad T cell receptor (TCR-) repertoire is required for an effective immune response. 
TCR-repertoire diversity declines with age. End-stage renal disease (ESRD) patients have 
a prematurely aged T  cell system which is associated with defective T  cell-mediated 
immunity. Recently, we showed that ESRD may significantly skew the TCR Vβ-repertoire. 
Here, we assessed the impact of ESRD on the TCR Vβ-repertoire within different T cell 
subsets using a multiparameter flow-cytometry-based assay, controlling for effects 
of aging and CMV latency. Percentages of 24 different TCR Vβ-families were tested 
in circulating naive and memory T cell subsets of 10 ESRD patients and 10 age- and 
CMV-serostatus-matched healthy individuals (HI). The Gini-index, a parameter used in 
economics to describe the distribution of income, was calculated to determine the extent 
of skewing at the subset level taking into account frequencies of all 24 TCR Vβ-families. In 
addition, using HI as reference population, the differential impact of ESRD was assessed 
on clonal expansion at the level of an individual TCR Vβ-family. CD8+, but not CD4+, 
T  cell differentiation was associated with higher Gini-TCR indices. Gini-TCR indices 
were already significantly higher for different CD8+ memory T cell subsets of younger 
ESRD patients compared to their age-matched HI. ESRD induced expansions of not 
one TCR Vβ-family in particular and expansions were predominantly observed within the 
CD8+ T cell compartment. All ESRD patients had expanded TCR Vβ-families within total 
CD8+ T cells and the median (IQ range) number of expanded TCR Vβ-families/patient 
amounted to 2 (1–4). Interestingly, ESRD also induced clonal expansions of TCR Vβ-
families within naive CD8+ T cells as 8 out of 10 patients had expanded TCR Vβ-families. 
The median (IQ range) number of expanded families/patient amounted to 1 (1–1) within 
naive CD8+ T cells. In conclusion, loss of renal function skews the TCR Vβ-repertoire 
already in younger patients by inducing expansions of different TCR Vβ-families within the 
various T cell subsets, primarily affecting the CD8+ T cell compartment. This skewed TCR 
Vβ-repertoire may be associated with a less broad and diverse T cell-mediated immunity.
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inTrODUcTiOn
End-stage renal disease (ESRD) patients have a decreased vaccination efficacy (1–4), an increased 
susceptibility for infection (5–7) and a higher risk for the development of tumors (8–11). Loss 
of renal function is associated with a prematurely aged T cell system (12), most likely caused by 
the uremia-induced proinflammatory environment (13). These uremia-induced effects on T cells 
are expressed as a decline in thymic output, a severe depletion of naive T cell compartment, a shift 
2Huang et al. ESRD Induces Clonal TCR-Vβ Expansions
Frontiers in Immunology | www.frontiersin.org December 2017 | Volume 8 | Article 1826
to more highly differentiated memory T cell subsets, attrition 
of T cell telomeres (14) and a defective T cell receptor (TCR)-
induced ERK phosphorylation (15).
A broad TCR-repertoire capable of recognizing a wide range 
of foreign antigens is crucial for adequate T cell-mediated immune 
responses (16). Most TCRs consist of an α and β chain and each 
chain is composed of a variable (V) and a constant (C) region (17). 
The TCR Vβ-repertoire can be assessed using several approaches 
such as gene scan spectratyping via a DNA-based PCR (18), Vβ-
family phenotyping by flow-cytometry (19–21), and assessment 
of clonal diversity via next generation sequencing (NGS) (22, 23). 
Gene scan spectratyping of the TCR Vβ-repertoire is at best a 
semiquantitative measurement. Both flow-cytometry and NGS 
result in a more accurate quantitative assessment of the TCR Vβ-
repertoire. As NGS is more labor-intensive and sorting of highly 
pure T cells or their subsets is required, many researchers prefer 
to use flow-cytometry. Flow-cytometry allows for measuring per-
centages of TCR Vβ-families at the T cell-subset level obviating 
the need for cell sorting.
We recently examined the TCR Vβ-repertoire in ESRD patients 
using multiplex DNA-based spectratyping. We showed ESRD to 
significantly and independently skew the TCR Vβ-repertoire in 
older individuals and this skewing was predominantly present 
within the CD8+ memory T  cell compartment (24). However, 
details of this skewed TCR Vβ-repertoire in ESRD patients are 
still lacking and quantitative data related to the impact of ESRD 
on TCR Vβ-repertoire in the various T cell populations is rare.
During aging, the TCR Vβ-repertoire has been reported to 
contract (25). Aging is associated with a decline in the naive T cell 
compartment which possess the broadest TCR repertoire (26), 
and a shift toward memory T cells, developing upon encountering 
of an antigen and having a skewed repertoire toward particular 
specificities (27, 28). The prevalence of CMV-seropositivity is 
high amongst ESRD patients, varying from 30 to 100%, depend-
ing on socioeconomic and ethnic background (29). CMV latency 
profoundly affects circulating T cells resembling features of aging, 
including increased frequencies of more differentiated memory 
T cells (30, 31) and loss of telomere length (32). CMV latency may 
also induce contraction of the TCR Vβ-repertoire as it induces 
expansion of CMV-specific T  cells immunocompetent donors 
(33) and these CMV-specific clones are stably maintained for 
5 years (34). Thus, TCR Vβ-repertoire diversity may be affected 
by various factors.
In this study, we assessed the TCR Vβ-repertoire diversity 
within different T  cell subsets in ESRD patients using a flow-
cytometry-based taking into account the effects of aging and 
CMV latency.
MaTerials anD MeThODs
study Population
A cohort of 10 stable ESRD patients, either younger individuals 
(n = 5, age < 45 years) or older individuals (n = 5, age ≥ 65 years) 
with an oligoclonal TCR Vβ-repertoire, as determined by DNA-
based spectratyping earlier (24) were studied in more detail at the 
T cell-subset level using a flow-cytometry based assay for TCR 
Vβ-repertoire analysis. Patients having a glomerular filtration 
rate below 15 mL/min and either or not receiving renal replace-
ment therapy (RRT) were included. Patients were excluded from 
the study when having a bacterial or viral infection, malignancy, 
a previous transplantation or taking immunosuppressive medica-
tion (except for glucocorticoids). The patient data are compared to 
those generated from 10 age- and CMV-matched healthy individ-
uals (HIs) with a polyclonal TCR Vβ-repertoire, as determined by 
DNA-based spectratyping (24). Lithium-heparinized blood was 
drawn from ESRD patients and HI. Written informed consent was 
obtained from all individuals included. The study was approved 
by the local medical ethical committee (METC number: 2012-
022) and conducted according to the principles of Declaration 
of Helsinki and in compliance with International Conference on 
Harmonization/Good Clinical Practice regulations.
sample Preparation
Peripheral blood mononuclear cells (PBMCs) were isolated from 
35 mL of lithium-heparinized blood by density centrifugation as 
described previously (35) and then frozen at 10 × 106 PBMC per 
vial at −190°C until further use.
Cryopreserved PBMCs (1 vial of 10  ×  106 PBMCs) were 
thawed, counted, washed and resuspended in Isoflow™ Sheath 
Fluid (Beckman Coulter B.V., Woerden, Netherlands). The 
PBMCs were stained with Brilliant Violet 510-labeled anti-CD3 
(BioLegend, Uithoorn, Netherlands), Alexa Fluor (AF)700-
labeled anti-CD4 (Beckman Coulter B.V.) and Allophycocyanin 
(APC)-Cy7-labeled anti-CD8 (BioLegend) to identify CD4+ and 
CD8+ within CD3+ T cells. ECD-labeled anti-CD45RO (Beckman 
Coulter B.V.), PE-Cy7-labeled anti-CCR7 (BD, Erembodegem, 
Belgium), V450-labeled anti-CD31 (BD; clone WM59), peridinin 
chlorophyll-A protein-Cy5.5-labeled anti-CD28 (BD) and APC-
labeled anti-CD57 (BioLegend) as well as fluorescence minus one 
controls were used to appropriately identify the different T cell 
subsets (illustrated in Figures S1B–D in Supplementary Material). 
As shown in Figure S1B in Supplementary Material, CCR7 and 
CD45RO are used to distinguish the different naive and memory 
T cell subsets, i.e., naive (CD45RO−CCR7+), central memory (CM, 
CD45RO+CCR7+), effector memory (EM, CD45RO+CCR7−), 
and terminally differentiated effector memory CD45RA+ T cells 
subsets (EMRA, CD45RO−CCR7−). CD31-expression within 
naive T cells (Figure S1C in Supplementary Material) identifies 
T cells that recently have left the thymus, also referred to as recent 
thymic emigrants (RTEs) (36). Loss of CD28 (CD28− T cells) and 
gain of CD57 (CD57+ T cells) expression is observed in relation 
to increased replicative history (37, 38) and allows for identifica-
tion of more differentiated T cells (Figure S1D in Supplementary 
Material).
Subsequently, the cell suspension was divided into eight 
tubes (100 μL/tube) labeled A-H, corresponding to the different 
antibody cocktails to stain for the 24 TCR Vβ-families (IOTest® 
Beta Mark TCR V beta repertoire kit, Beckman Coulter B.V.). 
Each cocktail contains antibodies directed to three different 
Vβ-families, i.e., one is fluorescein isothiocyanate (FITC-), one 
is PE-labeled and one is labeled with both FITC and PE. Table 1 
shows the description of the antibodies directed to the different 
TCR Vβ-families in tube A to H. A typical example of the propor-
tions of several TCR Vβ-families within CD3+ T cells from tube 
Table 1 | TCR Vβ-families in tube A-H.
Tube Vβ family Fluorochrome clone
A Vβ 5.3 PE 3D11
Vβ 3 FITC CH92
Vβ 7.1 PE + FITC ZOE
B Vβ 9 PE FIN9
Vβ 16 FITC TAMAYA1.2
Vβ 17 PE + FITC E17.5F3
C Vβ 18 PE BA62.6
Vβ 20 FITC ELL1.4
Vβ 5.1 PE + FITC IMMU157
D Vβ 13.1 PE IMMU222
Vβ 8 FITC 56C5.2
Vβ 13.6 PE + FITC JU74.3
E Vβ 5.2 PE 36213
Vβ 12 FITC VER2.32
Vβ 2 PE + FITC MPB2D5
F Vβ 23 PE AF23
Vβ 21.3 FITC IG125
Vβ 1 PE + FITC BL37.2
G Vβ 11 PE C21
Vβ 14 FITC CAS1.1.3
Vβ 22 PE + FITC IMMU546
H Vβ 13.2 PE H132
Vβ 7.2 FITC ZIZOU4
Vβ 4 PE + FITC WJF24
Detailed information with respect to the different TCR Vβ-family antibodies in tube A-H, 
labels and clones (IOTest® Beta Mark TCR V beta repertoire kit, Beckman Coulter).
Table 2 | Demographic and clinical characteristics of the study population.
healthy 
individuals
esrD 
patients
P-value
Number of individuals 10 10
Age (years; range)
younger group (<45 years) 36 (26–42) 28 (20–29) 0.06
older group (>65 years) 68 (65–73) 70 (65–73) 0.92
Sex (% male) 60 40 0.66
CMV IgG serostatus (% pos) 60 60 1.00
RRT (%) n.a. 70 n.a.
Duration of RRT (months; median/range) 20 (7–68)
Hemodialysis (%) 85.7
Peritoneal dialysis (%) 14.3
Underlying kidney disease
Primary glomerulopathy (%) 20
Diabetic nephropathy (%) 30
Reflux nephropathy (%) 10
Polycystic kidney disease (%) 20
Lupus nephritis (%) 10
Unknown (%) 10  
ESRD, end-stage renal disease; CMV, cytomegalovirus; pos, positive; RRT, renal 
replacement therapy; n.a., not applicable.
3
Huang et al. ESRD Induces Clonal TCR-Vβ Expansions
Frontiers in Immunology | www.frontiersin.org December 2017 | Volume 8 | Article 1826
A, tube B and tube C is depicted in Figure S1A in Supplementary 
Material, the last three plots.
The samples were measured on a Navios flow cytometer (10-
color configuration; Beckman Coulter B.V.) and at least 0.5 mil-
lion CD3+ T cells were acquired for each tube. Data were analyzed 
by Kaluza™ software (Beckman Coulter B.V.). The number of 
events acquired for a specific T  cell subset needed to be more 
than 100 to allow for reliable analysis of frequencies of TCR Vβ-
families within this population. The only subset that did not meet 
this criterion was the EMRA population within the CD4+ T cells.
gini-Tcr index and calculation of 
expanded Tcr Vβ−Families
The Gini index is used to describe the distribution of income in 
economic statistics. As the distribution of TCR Vβ−families shows 
similarities to that of income, the Gini index can also be applied 
in TCR Vβ-repertoire analysis by flow-cytometry. It has already 
been used in TCR-sequencing studies (39, 40), and was recently 
also introduced as an accurate and reliable way for analyzing 
TCR Vβ-repertoire data obtained by flow-cytometry (41). The 
TCR (Vβ)-Gini index with scores ranging from low to high indi-
cates TCR Vβ-families from equal distribution (broad repertoire; 
i.e., low score) to unequal distribution (skewed repertoire; 
i.e., high score). A Microsoft excel file allowing for automatic 
calculation of the Gini-TCR index using percentages of 24 TCR-
Vβ families is provided in the supporting file (41).
An expansion in a TCR Vβ-family in ESRD patients is defined 
as a frequency above the mean percentage + 2 times the SD of a 
certain TCR Vβ-family obtained using the HI as reference popu-
lation. By using this approach, finding an expansion by chance is 
lower than 2.5%.
statistical analyses
Gini-TCR indices or median number of expanded TCR Vβ-
families/individual between two different T  cell subsets within 
individuals were compared with Wilcoxon signed rank test and 
Friedman test followed by Dunn’s multiple comparison T-test was 
used for comparing more than two different T cell subsets. Trend 
analyses were performed using two-way ANOVA, comparing 
different subsets between individuals or CD4+ and CD8+ T cells. 
In addition, the effect of ESRD with respect to numbers of 
expanded TCR Vβ-families within different T  cell subsets is 
done using Fisher’s exact test. Two-sided P–values <0.05 were 
considered statistically significant. All statistical analyses were 
performed with GraphPad Prism 5.
resUlTs
study Population
Detailed information of the study population is given in Table 2. 
Ten ESRD patients (5 younger individuals: age 20–29 years and 
5 older individuals: age 65–73  years) and 10 age-matched HI 
(5 younger individuals age 26–42 years and 5 older individuals: 
age 65–73 years) were recruited into this study. Sixty percent of 
the ESRD and HI study population is CMV-seropositive. Seven 
out of 10 ESRD patients received RRT.
gini-Tcr indices increase with  
T cell Differentiation
Naive T  cells expressing CD31 are considered to be RTEs and 
the least-differentiated T  cell subset. In ESRD patients, CD31-
expressing naive T  cells tended to or have a lower Gini-TCR 
index when compared to their CD31− counterparts within CD4+ 
(Figure 1B) and CD8+ T cells (Figure 1D), respectively. For HI, 
FigUre 1 | Gini-T cell receptor (TCR) indices for different T cell subsets. The different Gini-TCR indices are depicted for healthy individual (HI) (a,c,e,g) and 
end-stage renal disease (ESRD) patients (b,D,F,h). First, the Gini-TCR indices for recent thymic emigrant (CD31+ naive) and CD31− naive CD4+ (a,b) and CD8+ T 
(c,D) cells are given, respectively. Next, the differentiation-associated effects on Gini-TCR indices are depicted for CD4+ (e,F) and CD8+ (g,h) T cell subsets, 
including naive, central memory, effector memory, and terminally differentiated effector memory CD45RA+ (EMRA) T cells. *, **, and *** reflect P-values <0.05, 0.01, 
and 0.001, respectively. Data from 10 HI and 10 ESRD patients are given as median with interquartile range.
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FigUre 2 | Effect of end-stage renal disease (ESRD) on Gini-T cell receptor 
(TCR) indices of CD8+ T cell subsets. In (a), the median and IQ range of the 
Gini-TCR indices for healthy individuals (N = 10) and ESRD patients (N = 10) 
for different CD8+ T cell subsets is depicted, whereas in (b,c) those for the 
younger and older group (N = 5) are given, respectively. P value: *<0.05.
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a significant lower Gini-TCR index was only observed for CD31-
expressing naive CD8+ (Figure 1C) but not CD4+ (Figure 1A) 
T cells when compared to CD31− naive T cells. Furthermore, a 
T cell differentiation-associated increase in Gini-TCR indices was 
noted for CD8+ (Figures 1G,H), but not CD4+ (Figures 1E,F), 
T  cells. The median value (IQ range) increased significantly 
(P <  0.001) from 36.5 (33.7–37) and 35.5 (33.8–37.9) in naive 
T cells to 49 (43–64.6) and 52.4 (44.9–72.8) in the highly differen-
tiated EMRA CD8+ T cells for HI and ESRD patients, respectively.
esrD Patients have increased gini-Tcr 
indices within Memory cD8+ T cell 
subsets
We next analyzed the influence of ESRD, aging, and CMV latency 
on skewing of the TCR Vβ-repertoire by comparing Gini-TCR 
indices for different T cell subsets including total CD3+ T cells, 
as well as naive, CD31+ naive, total memory (MEM), CM, EM, 
EMRA, CD28−, and CD57+ populations within both the CD4+ 
and CD8+ T cell subsets. ESRD effects with respect to Gini-TCR 
indices were limited to the CD8+ T cell compartment as it tended 
to induce higher Gini-TCR indices (P = 0.06) in CD8+ memory 
T cells when compared to HI (Figure 2A). The median (IQ range) 
value for Gini-TCR index in CD8+ memory T  cells amounted 
to 48.4 (45.8–63.3) and 43.8 (41.1–51.2) for ESRD patients and 
HI, respectively. Younger (Figure 2B), but not older (Figure 2C), 
ESRD patients had significantly higher Gini-TCR indices within 
the CD8+ CM (P < 0.05), EM (P < 0.05) and CD57+ T cell compart-
ment when compared to age-matched HI. The median (IQ range) 
for Gini-TCR in CD8+ CM, EM and CD57+ T cells amounted to 
47.4 (40.8–54.2) versus 35.3 (34.0–39.2), 54.4 (49.6–68.5) versus 
43.7 (42.4–50.8) and 77.6 (65.8–78.4) versus 59.2 (57.2–67.1) for 
younger ESRD patients versus younger HI.
The following results, describing Tables S1 and S2 in 
Supplementary Material need to be interpreted with caution as 
the P-values were not adjusted for the number of parameters 
compared.
Aging effects were not visible when comparing Gini-TCR 
indices for the different T cell subsets between younger and older 
ESRD patients (Table S1 in Supplementary Material). In HI, aging 
effects were confined to the CD8+ T  cell compartment and an 
aging-related increasing trend in Gini-TCR index was observed 
for CD8+ CM T cells (P = 0.06), as the median (IQ range) for 
Gini-TCR amounted to 40.1 (39.1–44.1) in older HI versus 
35.3 (34.0–39.2) in younger HI. An increased Gini-TCR index 
(P = 0.03) was observed for older HI, within CD8+CD28− T cells 
(Table S1 in Supplementary Material). The median (IQ range) 
value for Gini-TCR in CD8+CD28− T  cells amounted to 42.0 
(40.6–47.4) versus 57.8 (43.7–63.7) for younger and older HI, 
respectively.
CMV latency did not significantly affect Gini-TCR indices 
apart from a CMV-related increasing trend within CD4+CD57+ 
T cells (P = 0.07) of HI, but not ESRD patients, i.e., the median 
(IQ range) Gini-TCR index amounted to 67.0 (57.4–72.2) 
for CMV-seropositive HI versus 45.6 (35.5–58.0) for CMV-
seronegative ones (Table S2 in Supplementary Material). No 
differences were observed when comparing CMV-seronegative 
and CMV-seropositive ESRD patients to their CMV-serostatus 
matched HI with respect to Gini-TCR indices for the different 
T cell subsets (data not shown).
clonal expansions of Tcr Vβ-Families in 
Different T cell subsets
Apart from characterizing the impact of ESRD on Gini-TCR 
indices for the different T cell subsets, we also evaluated the impact 
of ESRD on clonal expansions of TCR Vβ-families by comparing 
frequencies to the average + 2SD obtained using HI as reference 
population. Figure 3 shows a typical example of expanded TCR 
Vβ-families within CD8+ memory T cells of ESRD patients.
Clonal expansions of TCR Vβ-families were observed within 
the CD3+ T cells in 7 out of 10 ESRD patients (Table 3). Half ver-
sus all of the ESRD patients showed expanded TCR Vβ-families 
Table 3 | Effect of ESRD on expansions of TCR Vβ-families.
# of esrD patients 
with/without 
expansions
Median # of 
expanded Tcr Vβ-
families (iQ range)
Total # of 
expanded Tcr 
Vβ-families
CD3+ 7/3 1 (0–2) 15
CD4+ 5/5 1 (0–2) 10
CD31+ naive 6/4 1 (0–1) 9
Naive 3/7 0 (0–1) 5
MEM 9/1 1 (1–3) 16
CM 6/4 1 (0–2) 11
EM 6/4 1 (0–2) 13
CD28− 9/1 1 (1–1) 12
CD57+ 9/1 1 (0–2) 11
CD8+ 10/0 2 (1–4) 26
CD31+ naive 7/3 1 (0–2) 15
Naive 8/2 1 (1–1) 12
MEM 10/0 2 (2–4) 28
CM 7/3 2 (0–3) 20
EM 9/1 4 (2–4) 32
EMRA 10/0 2 (1–3) 26
CD28− 10/0 3 (1–3) 28
CD57+ 9/1 3 (1–4) 25
FigUre 3 | Expansions of T cell receptor (TCR) Vβ-families within CD8+ memory T cells from end-stage renal disease (ESRD) patients. Boxes and error bars 
represent the mean and 95% confidence interval (mean ± 2SD) of 24 TCR-Vβ families from 10 healthy individuals (HI). Red dots correspond to expanded TCR 
Vβ-families from ESRD patients (frequencies > mean + 2SD from HI).
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within CD4+ and CD8+ T cells (P < 0.05), respectively. The median 
(IQ range) number of expanded TCR Vβ-families per patient 
amounted to 1 (0–2) and 2 (1–4) families for CD4+ and CD8+ 
T cells (P < 0.05), respectively (Figure 4A). Interestingly, expan-
sions were also detected within the naive T cell compartment, as 
3 out of 10 and 8 out of 10 patients had expansions of TCR Vβ-
families within the naive CD4+ and CD8+ T cell compartment, 
respectively (Table  3). Most clonal expansions were observed 
within the (more differentiated) memory CD8+ T  cell subsets 
(Figure 4A). The median (IQ range) number of expanded TCR 
Vβ-families amounted to 1 (1–1) versus 2 (2–4) for naive and 
memory CD8+ T cells, respectively (P < 0.05). Moreover, ESRD 
affected different TCR Vβ-families as illustrated in Figure 3 for 
CD8+ memory T  cells. ESRD induced expansions within both 
younger (Figure 4B) and older (Figure 4C) ESRD patients when 
compared to their age-matched HI.
DiscUssiOn
The main finding of this study is that the multiparameter flow-
cytometry-based approach for evaluating the skewed TCR Vβ-
repertoire diversity in ESRD patients showed that TCR skewing 
can be observed primarily in CD8+ T cell subsets, including naive 
T  cells. However, higher Gini-TCR indices, indicative for an 
enhanced TCR Vβ-repertoire skewing, were specifically associ-
ated with more differentiated CD8+, but not CD4+, T cell subsets 
in both ESRD patients and HI.
Our previous data showed that ESRD may lead to a skewed 
TCR Vβ-repertoire as assessed by DNA spectratyping, providing 
at best semiquantitative information about TCR Vβ-clonality 
(24). The current study provided more quantitative details 
with respect to this skewed TCR Vβ-repertoire at the T  cell-
subset level using the Gini-TCR index as a tool for calculating 
skewness (41) and evaluating number/type of expanded TCR 
Vβ-families. Higher Gini-TCR indices are indicative of a more 
skewed TCR Vβ-repertoire. The current study confirmed several 
of our previous findings. Increased skewing of the TCR Vβ-
repertoire was observed for more differentiated CD8+, but not 
CD4+, T cells, corresponding to our spectratyping data as well 
as findings described by others (27, 42). In addition to the Gini-
TCR index, we calculated the number of TCR Vβ-families per 
patient that were expanded beyond the mean +  2SD values of 
HI. This approach yielded similar results as the Gini-index but 
gives detailed information at the individual patient level for the 
different T cell subsets. For instance some patients have a large 
number of expanded TCR Vβ-families while others show only 
a few. Moreover, ESRD did not seem to affect one TCR Vβ-family 
in particular, indicative of expansions of different clonal origin. 
Altogether, using both Gini-TCR indices as well as the number 
of expanded TCR Vβ-families, revealed skewing to mainly occur 
FigUre 4 | End-stage renal disease effect on T cell receptor (TCR) Vβ-families within T cell subsets. Using healthy individual (HI) (N = 10) as a reference population, 
we evaluated the number of TCR Vβ-families that were expanded per patient for a T cell subset (frequency of a TCR Vβ-family exceeding the mean + 2SD value 
obtained for HI) (a). In (b,c), the median (IQ range) of expansions per younger and older patient for a T cell subset is depicted using the younger (N = 5) and older 
HI (N = 5) as a reference, respectively. The open bars represent the median and IQ range for the different CD4+ T cell subsets, whereas the closed bars represent 
that for the different CD8+ T cell subsets.
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within the CD8+ and in particular within the CD8+ memory 
T  cell subset similar to what was observed before using DNA-
based spectratyping on sorted T cell subsets (24).
The commercially available flow-cytometry-based assay, 
used to characterize the TCR Vβ-repertoire, is composed of 24 
different TCR Vβ-antibodies covering about 70% of the nor-
mal human TCR Vβ-repertoire (brochure Beckman Coulter). 
Evaluating other TCR Vβ-families as well as TCR Vα and TCR 
Vγ/Vδ families may contribute to a better understanding of the 
whole TCR-repertoire. In this respect, γδ+ T  cells account for 
approximately 8% of CD3+ peripheral blood T cells and around 
6% of γδ+ T cells were observed within CD3+CD8+, but not CD4+ 
T cells in HI (19). As frequencies of γδ+ T cells may also vary 
amongst individuals, it might be more accurate to evaluate the 
TCR Vβ-repertoire not within total CD3+, like performed in the 
current study, but within αβ+ CD3+ T cells.
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Interestingly, using this multiparameter flow-cytometry-based 
approach, we were also able to detect expanded TCR Vβ-families 
within the naive T cell compartment. This characteristic has, to 
our knowledge never been described for ESRD patients. Uremia 
induces a proinflammatory environment significantly affecting 
T  cell-mediated immunity characterized by increased risk for 
infections (5) and decreased vaccination efficacy (1, 43). We have 
observed that progressive loss of renal function is accompanied 
by a severe depletion of the naive T  cell compartment and a 
relative shift toward more differentiated memory T  cells (44). 
Naive T  cells employ a mechanism referred to as homeostatic 
proliferation in order to maintain the naive T cell pool that is not 
replenished by newly developed naive T cells from the thymus 
due to thymic involution. Homeostatic proliferation occurs 
in response to homeostatic cytokines, e.g., IL-7, or low affinity 
self antigens presented by antigen-presenting cells (26). This 
mechanism has been described to be associated with a decline in 
TCR Vβ-repertoire diversity within naive T cells with increasing 
age (27, 45). ESRD enhanced homeostatic proliferation of naive 
T cells to a similar extent as observed in older HI (12) and as a 
consequence of this compensatory mechanism, loss of TCR Vβ-
repertoire diversity may also be induced by ESRD within naive 
CD8+ and/or CD4+ T cells.
Naive T cells are required to mount adequate immune responses 
to newly encountered antigens (46, 47). ESRD patients, with a 
severely depleted naive T cell compartment (44), are hampered in 
inducing adequate protection to, for example, HBV vaccination 
as a result of defective generation of antigen-specific memory 
T  cells (43). The ESRD-associated defects in T  cell composi-
tion as well as function, reminiscent of aging-associated T cell 
defects, led to the concept of premature T cell aging introduced 
in 2011 (12). ESRD patients have a T cell compartment that is 
aged by 15–20 years compared to their chronologic age, using 
age-matched HI as a reference. Consistent with premature 
T  cell aging (12), we observed ESRD-associated increases in 
Gini-TCR indices and TCR Vβ expansions to occur already at 
young age.
Aging is known to affect TCR Vβ-repertoire diversity toward 
a more skewed pattern, starting from roughly 600 × 103 clono-
types detected per 106 T cells in childhood, declining by 5 × 103 
clonotypes per year (25). Age-related effects were limited within 
our cohort of HI and this may be a consequence of the selection 
procedure applied. We did select HI with a polyclonal (i.e., non-
skewed) TCR Vβ-repertoire using DNA-based spectratyping 
(24), to ensure a relatively standard healthy population to be used 
as reference for comparison to ESRD patients. The ESRD patient 
population however only consisted of individuals with an oligo-
clonal (skewed) TCR Vβ-repertoire. This might have resulted in 
an underestimation of the effect of aging on TCR Vβ-families. 
Likewise, our selection procedure may also explain the minimal 
effects of CMV in both cohorts.
CMV latency is known to introduce skewing of the TCR 
Vβ-repertoire induced by expanded CMV-specific T cell clones 
in both HI (33, 34, 48) and ESRD patients (24). CMV latency 
may result in a vast and long-lasting expansion of CMV-specific 
T  cells (33, 34). Moreover, CMV latency has additional effects 
mainly on circulating CD8+ T cells of ESRD patients (49).
End-stage renal disease, aging, and CMV all influenced the 
TCR-Vβ repertoire diversity to a different extent (24), however, 
because of different factors present in the environment, they all 
have their specific effect on clonotype selection. Even though 
these findings need to be verified in a larger cohort without 
preselection using DNA-based spectratyping of TCR-Vβ-
repertoire, our study already shed some light on this altered 
TCR-Vβ repertoire at the T cell-subset level in particular with 
respect to ESRD.
Relating TCR-repertoire data to functional capacities of 
T  cells is warranted to increase knowledge on uremia-induced 
T cell defects in ESRD patients. Moreover, tracking TCR clones in 
whole blood or tissue infiltrates may provide additional informa-
tion on antigen specificity important for diagnosis of infection 
and allograft rejection after transplantation (50–52).
In conclusion, ESRD is associated with a skewed TCR Vβ-
repertoire as a result of variable TCR Vβ-family expansions, 
but not one TCR Vβ-family in particular. ESRD, aging and 
CMV latency exert their effects by influencing different TCR 
Vβ-families. This altered repertoire may be associated with a less 
broad and less diverse T cell-mediated immunity.
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